CMS 134 - Diabetes: Medical Attention for Nephropathy

Edit in Google Drive

Overview

CMS134v8 (2020)

CMS134v9 (2021)

CMS134v10 (2022)

Identifiers

CMS eCQM ID NQF eCQM ID NQF MIPS Quality ID
CMS134v10 – 0062 119

*MIE only supports data collection and reporting using eCQM specifications

Definitions

Description The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period
Initial Patient Population Patients 18-75 years of age with diabetes with a visit during the measurement period
Denominator Equals Initial Population
Denominator Exclusions
  • Exclude patients who are in hospice care for any part of the measurement period.
  • Exclude patients 66 and older who are living long term in an institution for more than 90 consecutive days during the measurement period.
  • Exclude patients 66 and older with an indication of frailty for any part of the measurement period who meet any of the following criteria:
    • Advanced illness with two outpatient encounters during the measurement period or the year prior
    • Advanced illness with one inpatient encounter during the measurement period or the year prior
    • Taking dementia medications during the measurement period or the year prior
  • Exclude patients receiving palliative care during the measurement period.
Numerator Patients with a screening for nephropathy or evidence of nephropathy during the measurement period
Numerator Exclusions –
Denominator Exceptions –

Additional Information

Measure Type Process measure
Measure Scoring Proportion measure
Granularity Patient
Improvement Notation Higher score indicates better quality
Domain Effective Clinical Care

Clinical Instructions

New UI Visit Encounter (valid RC202109+)

Original Visit Encounter

Evidence

Initial Patient Population

Name Value Set
Diagnosis: Diabetes 2.16.840.1.113883.3.464.1003.103.12.1001
Encounter, Performed: Annual Wellness Visit 2.16.840.1.113883.3.526.3.1240
Encounter, Performed: ESRD Monthly Outpatient Services 2.16.840.1.113883.3.464.1003.109.12.1014
Encounter, Performed: Home Healthcare Services 2.16.840.1.113883.3.464.1003.101.12.1016
Encounter, Performed: Observation 2.16.840.1.113883.3.464.1003.101.12.1086
Encounter, Performed: Office Visit 2.16.840.1.113883.3.464.1003.101.12.1001
Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1025
Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1023
Encounter, Performed: Telephone Visits 2.16.840.1.113883.3.464.1003.101.12.1080

Denominator Exclusions

Name Value Set
Assessment, Performed: Functional Assessment of Chronic Illness Therapy - Palliative Care Questionnaire (FACIT-Pal) LOINC Code 71007-9
Device, Applied: Frailty Device 2.16.840.1.113883.3.464.1003.118.12.1300
Device, Order: Frailty Device 2.16.840.1.113883.3.464.1003.118.12.1300
Diagnosis: Frailty Diagnosis 2.16.840.1.113883.3.464.1003.113.12.1074
Encounter, Performed: Acute Inpatient 2.16.840.1.113883.3.464.1003.101.12.1083
Encounter, Performed: Care Services in Long-Term Residential Facility 2.16.840.1.113883.3.464.1003.101.12.1014
Encounter, Performed: Emergency Department Visit 2.16.840.1.113883.3.464.1003.101.12.1010
Encounter, Performed: Encounter Inpatient 2.16.840.1.113883.3.666.5.307
Encounter, Performed: Frailty Encounter 2.16.840.1.113883.3.464.1003.101.12.1088
Encounter, Performed: Nonacute Inpatient 2.16.840.1.113883.3.464.1003.101.12.1084
Encounter, Performed: Nursing Facility Visit 2.16.840.1.113883.3.464.1003.101.12.1012
Encounter, Performed: Observation 2.16.840.1.113883.3.464.1003.101.12.1086
Encounter, Performed: Outpatient 2.16.840.1.113883.3.464.1003.101.12.1087
Encounter, Performed: Palliative Care Encounter 2.16.840.1.113883.3.464.1003.101.12.1090
Intervention, Order: Hospice care ambulatory 2.16.840.1.113762.1.4.1108.15
Intervention, Performed: Hospice care ambulatory 2.16.840.1.113762.1.4.1108.15)
Intervention, Performed: Palliative Care Intervention 2.16.840.1.113883.3.464.1003.198.12.1135
Medication, Active: Dementia Medications 2.16.840.1.113883.3.464.1003.196.12.1510
Symptom: Frailty Symptom 2.16.840.1.113883.3.464.1003.113.12.1075

Numerator

Name Value Set
Diagnosis: Diabetic Nephropathy 2.16.840.1.113883.3.464.1003.109.12.1004
Diagnosis: Glomerulonephritis and Nephrotic Syndrome 2.16.840.1.113883.3.464.1003.109.12.1018
Diagnosis: Hypertensive Chronic Kidney Disease 2.16.840.1.113883.3.464.1003.109.12.1017
Diagnosis: Kidney Failure 2.16.840.1.113883.3.464.1003.109.12.1028
Diagnosis: Proteinuria 2.16.840.1.113883.3.526.3.1003
Intervention, Performed: Dialysis Education 2.16.840.1.113883.3.464.1003.109.12.1016
Intervention, Performed: Other Services Related to Dialysis 2.16.840.1.113883.3.464.1003.109.12.1015
Laboratory Test, Performed: Urine Protein Tests 2.16.840.1.113883.3.464.1003.109.12.1024
Medication, Active: ACE Inhibitor or ARB or ARNI 2.16.840.1.113883.3.526.3.1139
Procedure, Performed: Dialysis Services 2.16.840.1.113883.3.464.1003.109.12.1013
Procedure, Performed: Kidney Transplant 2.16.840.1.113883.3.464.1003.109.12.1012

Source(s)

eCQI CMS134

Was this page helpful?

Let us know how we can improve this documentation.

Published: April 22, 2022